Arizona Advanced Arrhythmias — Gilbert, Arizona

Arizona Advanced Arrhythmias is a clinical research site located in Gilbert, Arizona, United States 85297.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Arizona Advanced Arrhythmias has participated in 1 clinical trials.

Therapeutic areas: Heart Failure.

Sponsors: Boston Scientific Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Gilbert

Browse all research sites in Arizona · View every site in Gilbert

• ACS-Mesa General Hospital
• Phoenix Memorial Hospital
• University of Arizona Arthritis Center
• Mayo Clinic Hospital
• Banner MD Anderson Cancer Center
• Research Site
• Mercy Gilbert Medical Center
• GSK Investigational Site
• Arizona Center for Cancer Care - Gilbert
• Banner MD Anderson
• Banner Health MD Anderson Cancer Center
• Pfizer Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Arizona Advanced Arrhythmias?

Arizona Advanced Arrhythmias has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Arizona Advanced Arrhythmias conducted?

Arizona Advanced Arrhythmias has 1 clinical trials on record. Their work covers Heart Failure.

Is Arizona Advanced Arrhythmias accredited by Crixeo Clinical Trials?

Arizona Advanced Arrhythmias has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Arizona Advanced Arrhythmias?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.